Stephen George Dilly's Net Worth
$22.4 Million
Who is Stephen George Dilly?
Stephen George Dilly has an estimated net worth of $22.4 Million. This is based on reported shares across multiple companies, which include CODEXIS, INC., SANGAMO BIOSCIENCES INC, Sierra Oncology, Inc., Aimmune Therapeutics, Inc., and AVIGEN INC \DE.
SEC CIK
Stephen George Dilly's CIK is 0001389147
Past Insider Trading and Trends
2018 was Stephen George Dilly's most active year for acquiring shares with 9 total transactions. Stephen George Dilly's most active month to acquire stocks was the month of May. 2018 was Stephen George Dilly's most active year for disposing of shares, totalling 17 transactions. Stephen George Dilly's most active month to dispose stocks was the month of May. 2018 saw Stephen George Dilly paying a total of $906,630.00 for 317,500 shares, this is the most they've acquired in one year. In 2017 Stephen George Dilly cashed out on 400,000 shares for a total of $10,562,715.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CODEXIS, INC. (CDXS) Snapshot price: $2.74
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +32.68% | 143.43K |
—
|
—
| 582.3K |
Jan 1
| |||
Form 4
| +15.37% | 58.48K |
$1.73 | $100,952.30 | 438.88K |
Sep 8
| |||
Form 4
| +159.70% | 233.93K |
$4.58 | -$252,211.82 | 380.4K |
Feb 8 - Mar 8
| |||
Form 4
| +331.14% | 112.5K |
—
|
—
| 146.47K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| +49.66% | 11.27K |
—
|
—
| 33.97K |
Jun 14
| |||
Form 4
| +26.79% | 4.8K |
—
|
—
| 22.7K |
Jun 15
| |||
Form 4
|
∞
| 17.91K |
—
|
—
| 17.91K |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SANGAMO BIOSCIENCES INC (SGMO) Snapshot price: $0.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +200.00% | 10K |
—
|
—
| 15K |
May 18
| |||
Form 4
| +50.00% | 2.5K |
—
|
—
| 7.5K |
May 18
| |||
Form 4
|
—
|
0
|
$5.71 | -$20,300.00 | 5K |
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
$5.72 | -$8,961.00 | 5K |
Scheduled
|
Mar 16
| ||
Form 4
| +100.00% | 2.5K |
—
|
—
| 5K |
Jun 10
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sierra Oncology, Inc. No price found
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.00K |
$55.00 | -$275,000.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
∞
| 5K |
$17.83 | $89,150.00 | 5K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aimmune Therapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$16.93 | -$819,278.70 | 315.31K |
Scheduled
|
Jun 11
| ||
Form 4
|
—
|
0
|
$16.97 | -$2,934,161.47 | 315.31K |
Scheduled
|
Jun 6 - Jun 8
| ||
Form 4
|
—
|
0
|
$17.58 | -$4,815,406.46 | 364.86K |
Scheduled
|
Oct 12 - Jun 5
| ||
Form 4
| -24.08% | -100.00K |
$33.55 | -$3,354,538.10 | 315.31K |
Scheduled
|
Oct 23
| ||
Form 4
| -0.28% | -1.15K |
$26.24 | -$30,278.65 | 415.31K |
Scheduled
|
Oct 16
| ||
Form 4
| -19.18% | -98.85K |
$26.24 | -$2,593,316.98 | 416.46K |
Scheduled
|
Oct 4 - Oct 6
| ||
Form 4
| -13.93% | -100.00K |
$25.01 | -$2,500,790.00 | 618.11K |
Scheduled
|
Aug 23 - Sep 25
| ||
Form 4
| -7.52% | -50.00K |
$21.46 | -$1,073,110.00 | 615.31K |
Scheduled
|
Jul 26
| ||
Form 4
| -6.91% | -49.40K |
$20.21 | -$998,591.36 | 665.31K |
Scheduled
|
Jun 23
| ||
Form 4
| -0.08% | -600.00 |
$20.15 | -$12,090.00 | 714.71K |
Scheduled
|
May 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| -5.57% | -50.00K |
$25.01 | -$1,250,590.03 | 847.01K |
Scheduled
|
Jul 25 - Nov 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AVIGEN INC \DE No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |